` 539470 (Shree Ganesh BioTech India Ltd) vs KSCL (Kaveri Seed Company Ltd) Comparison - Alpha Spread

S
539470
vs
KSCL

Over the past 12 months, SHREEGANES has outperformed KSCL, delivering a return of -28% compared to the KSCL's 37% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
539470
KSCL
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

SHREEGANES Intrinsic Value
LOCKED
Unlock
KSCL Intrinsic Value
LOCKED
Unlock
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
S
Shree Ganesh BioTech India Ltd
BSE:539470
0.68 INR
Kaveri Seed Company Ltd
NSE:KSCL
933.6 INR
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
539470, KSCL

539470
KSCL
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
S
Shree Ganesh BioTech India Ltd
Revenue
Kaveri Seed Company Ltd
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
539470, KSCL

539470
KSCL
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
S
Shree Ganesh BioTech India Ltd
BSE:539470
Kaveri Seed Company Ltd
NSE:KSCL
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

SHREEGANES
-9.7%
KSCL
48%

Operating Margin

SHREEGANES
-33.2%
KSCL
20.1%

Net Margin

SHREEGANES
-6.7%
KSCL
21.8%

FCF Margin

SHREEGANES
-186.1%
KSCL
-12.2%

ROE

SHREEGANES
-0.6%
KSCL
18%

ROA

SHREEGANES
-0.6%
KSCL
11.8%

ROIC

SHREEGANES
-4.5%
KSCL
16.4%

ROCE

SHREEGANES
-3.1%
KSCL
16%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
539470, KSCL

Loading
539470
KSCL
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
539470, KSCL

Performance Gap Between 539470 and KSCL
LOCKED
Unlock

Performance By Year
539470, KSCL

Loading
539470
KSCL
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 539470 to other stocks
KWS
KWS SAAT SE & Co KgaA
Cheaper
vs SHREEGANES
002041
Shandong Denghai Seeds Co Ltd
S
More expensive
vs SHREEGANES
600354
Gansu Dunhuang Seed Group Co L...
Cheaper
vs SHREEGANES
600371
Wanxiang Doneed Co Ltd
W
More expensive
vs SHREEGANES
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett